Pharmafile Logo
Pharmafocus logo
Advanced Search
Biogen Idec image

Biogen Idec buys Convergence

January 14, 2015
Sales and Marketing BG00010, Biogen IDEC, CNV1014802, Colombia University Medical Center, Convergence, Neublastin

Biogen Idec is to acquire independent UK-based Convergence Pharmaceuticals to strengthen its pipeline of drugs for pain management in a …

News

BMS Opdivo trial scores early goal

January 14, 2015
Research and Development, Sales and Marketing BMS, Merck, cancer nsclc, keytruda, nivolumab, opdivo

A late-stage trial of Bristol-Myers Squibb’s lung cancer drug Opdivo has been stopped early after showing promising results – but …

News
eliot_forster_immunocore_portrait_2

Immunocore names chief executive

January 14, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eliot Forster, immunocore

Oxford-based biotec Immunocore has announced the appointment of Dr Eliot Forster as its chief executive with immediate effect. Forster takes …

Appointment
Lilly image

Lilly, BMS and Merck unite for cancer trials

January 13, 2015
Research and Development, Sales and Marketing BMS, Cancer, Galunisertib, Merck, NSCLC, keytruda, lilly, oncology, opdivo

Lilly will test some of its compounds in combination with rival cancer drugs from Bristol-Myers Squibb and Merck, the companies …

News
Roche image

Roche teams up to tackle antibiotics resistance

January 13, 2015
Research and Development, Sales and Marketing Antibiotics, Fedora, Meiji, OP0595, Roche, Teixobactin

Roche is to collaborate with Japan-based pharma firm Meiji and Canadian Fedora – two companies specialising in the production of …

News

New UCB chief starts and expands team

January 13, 2015
Sales and Marketing Cimzia, Jean-Christophe Tellier, Neupro, UCB, roch deliveux, vimpat

New UCB chief executive Jean-Christophe Tellier who succeeded Roch Doliveux this year has also welcomed three new members to the …

News
AMRI image

AMRI buys two Aptuit facilities

January 13, 2015
Manufacturing and Production AMRI, Aptuit, cedarburg, glasgow, oso

Contract research and manufacturing firm AMRI has acquired two businesses from pharmaceutical services company Aptuit in a $60 million deal. …

News
greg_weaver

Oryzon Genomics names CFO and executive VP

January 13, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gregory Weaver, Oryzon genomics

Spanish clinical stage biopharma firm Oryzon Genomics has appointed Gregory Weaver as its executive vice president and chief financial officer. …

Appointment
dendreon image

Another NICE no for Dendreon cancer drug

January 13, 2015
Sales and Marketing Cancer, Dendreon, FDA, NHS, NICE, Provenge, sipuleucel-T

Dendreon has seen its prostate cancer treatment for people whose disease has spread and who are not yet suitable for …

News

NHS drops 25 treatments from Cancer Drugs Fund

January 12, 2015
Sales and Marketing Afinitor, CDF, Cancer, Cancer Drugs Fund, Eisa, Halaven, Heribulin, Jevtana, NHS, Sanofi, Zaltrap, aflibercept, cabazitaxel, everolimus

Twenty-five cancer treatments will be removed from the Cancer Drugs Fund list, NHS England has announced. Having concluded its review …

News
AZ image

AstraZeneca drops CDF application

January 12, 2015
Sales and Marketing AstraZeneca, CDF, Cancer, NHS, NICE, lynparza, olaparib

AstraZeneca has withdrawn its application for its drug Lynparza to be on the Cancer Drugs Fund (CDF), citing concerns with …

News
Novartis image

Novartis enters digital tech collaboration

January 12, 2015
Sales and Marketing Novartis, clinical trials, digital, mhealth, qualcomm, ventures

Novartis has entered an agreement with the US investment company Qualcomm Ventures to create a joint firm to support the …

News
Shire image

Shire buys rare-disease firm NPS Pharma

January 12, 2015
Sales and Marketing AbbVie, Shire, gattex, natpara, nps, nps pharma

Shire is to acquire rare diseases firm NPS Pharma to enhance its profile following the collapse of its deal with …

News
Roche image

Roche stakes $1 billion in cancer gene research firm

January 12, 2015
Research and Development, Sales and Marketing Cancer, Foundation Medicine, Genentech, Roche, genomics, jp morgan

Roche has announced a huge billion-dollar investment in the cancer genomics research firm Foundation Medicine. Timed with the beginning of …

News
Daiichi image

Daiichi-Sankyo pays $39m to settle allegations

January 12, 2015
Sales and Marketing Azor, Benicar, Daiichi Sankyo, Daiichi-Sankyo, Tribenzor, Welchol, kickbacks, us justice

Daiichi-Sankyo will pay the US government and state Medicaid programmes $39 million to resolve claims that it violated the False …

News
FDA image

FDA approvals: 1996 versus 2014

January 12, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, John LaMattina, LaMattina, NDA, US, appovals, drugs

As highlighted in a number of recent stories, 2014 was a banner year for the biopharmaceutical industry with 41 new …

Feature
atul_pande

Heptares Therapeutics hires former GSK heads

January 12, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Atul Pande, GSK, Heptares, Roberto Solari

UK and US-based clinical-stage drug firm Heptares Therapeutics has appointed Atul Pande and Roberto Solari to its board of directors. …

Appointment
Daiichi image

Daiichi-Sankyo blood drug gets FDA nod

January 12, 2015
Sales and Marketing BMS, Daiichi Sankyo, Daiichi-Sankyo, FDA, Pfizer, Pradaxa, atrial fibrillation, blood, savaysa

The US Food and Drug Administration has shown Daiichi-Sankyo’s anti-clotting drug Savaysa the green light to reduce the risk of …

News
Biogen Idec image

Mixed results for Biogen’s MS drug

January 9, 2015
Sales and Marketing Anti-LINGO-1, BIIB033, Biogen IDEC, MS, multiple sclerosis, plegridy

An experimental drug from Biogen Idec for the treatment of multiple sclerosis (MS) has shown a mixed bag of results …

News
Takeda image

Takeda trials Teva Parkinson’s drug in Japan

January 9, 2015
Sales and Marketing Azilect, CHMP, Copaxone, Parkinson's, Takeda, rasagiline

Takeda has begun late stage trials for Teva’s Parkinson’s disease drug Azilect in Japan, with the hopes of bringing the …

News
The Gateway to Local Adoption Series

Latest content

Campaign highlights low expectations among patients with depression

May 7, 2026

Practical AI toolkit launched to help manufacturers cut through complexity

May 6, 2026

Syngene appoints Maninder Kapoor Puri as CHRO

May 6, 2026

BioPhorum acquires PharmaX Solutions

May 5, 2026

Syngene appoints Abhijit Zutshi as CCO

May 5, 2026